| USP-1A02060 |
trans-Cholecalciferol (25 mg) (需冷链运输) |
22350-41-0 |
|
| 2906195000 |
|
|
|
| USP-1012906 |
Alfentanil Hydrochloride CII (500 mg) |
70879-28-6 |
UN2811 |
| USP-1015008 |
Alprazolam CIV (200 mg) |
28981-97-7 |
|
| 2933910000 |
|
|
|
| USP-1030001 |
Amobarbital CII (25 mg) |
57-43-2 |
UN2811 |
| USP-1042758 |
Armodafinil CIV (500 mg) |
112111-43-0 |
|
| 2930902000 |
|
|
|
| USP-1059003 |
Benzphetamine Hydrochloride CIII (200 mg) |
5411-22-3 |
UN2811 |
| USP-1059014 |
Benzphetamine Related Compound A CIII (30 mg) ((R)-N-Benzyl-N-methyl-1-phenylpropan-2-amine hydrochloride) |
28646-36-8 |
|
| 2921490002 |
|
|
|
| USP-1076465 |
Bromazepam CIV (100 mg) (AS) |
1812-30-2 |
|
| 2933330100 |
|
|
|
| USP-1078700 |
Buprenorphine Hydrochloride CIII (50 mg) |
53152-21-9 |
|
| 2939110000 |
|
|
|
| USP-1078711 |
Buprenorphine Related Compound A CII (25 mg) ((S)-2-[17-(But-3-en-1-yl)-4,5alpha-epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl]- 3,3-dimethylbutan-2-ol) |
457071-73-7 |
|
| 2939190000 |
|
|
|
| USP-1078722 |
Buprenorphine System Suitability Mixture CII (50 mg) (Mixture of Buprenorphine and about 0.5% of Ethenobuprenorphine) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1079000 |
Butabarbital CIII (200 mg) |
125-40-6 |
UN2811 |
| USP-1081002 |
Butalbital CIII (200 mg) |
77-26-9 |
UN2811 |
| USP-1082504 |
Butorphanol Tartrate CIV (350 mg) |
58786-99-5 |
|
| 2933492250 |
|
|
|
| USP-1096600 |
Carisoprodol CIV (1 g) |
78-44-4 |
|
| 2924190002 |
|
|
|
| USP-1096804 |
Cathinone Hydrochloride CI (50 mg) (alpha-Aminopropiophenone Hydrochloride) |
16735-19-6 |
|
| 2939800000 |
|
|
|
| USP-1109000 |
Chlordiazepoxide CIV (200 mg) |
58-25-3 |
|
| 2933910000 |
|
|
|
| USP-1110009 |
Chlordiazepoxide Hydrochloride CIV (200 mg) |
438-41-5 |
|
| 2933910000 |
|
|
|
| USP-1140305 |
Clonazepam CIV (200 mg) |
1622-61-3 |
|
| 2933910000 |
|
|
|
| USP-1140509 |
Clorazepate Dipotassium CIV (125 mg) |
57109-90-7 |
|
| 2933910000 |
|
|
|
| USP-1143008 |
Cocaine Hydrochloride CII (250 mg) |
53-21-4 |
UN1544 |
| USP-1143802 |
Codeine N-Oxide CI (30 mg) |
3688-65-1 |
|
| 2939110000 |
|
|
|
| USP-1144000 |
Codeine Phosphate CII (100 mg) |
41444-62-6 |
UN1544 |
| USP-1145003 |
Codeine Sulfate CII (250 mg) |
6854-40-6 |
|
| 2939110000 |
|
|
|
| USP-1145025 |
Codeine System Suitability Mixture CI (25 mg) |
N/A |
UN2811 |
| USP-1180004 |
Dextroamphetamine Sulfate CII (500 mg) |
51-63-8 |
UN2811 |
| USP-1185008 |
Diazepam CIV (100 mg) |
439-14-5 |
UN2811 |
| USP-1194009 |
Diethylpropion Hydrochloride CIV (200 mg) |
134-80-5 |
UN2811 |
| USP-1200804 |
Dihydrocodeine Bitartrate CII (200 mg) |
5965-13-9 |
|
| 2939110000 |
|
|
|
| USP-1219008 |
Diphenoxylate Hydrochloride CII (200 mg) |
3810-80-8 |
UN2811 |
| USP-1219019 |
Diphenoxylate Related Compound A CI (25 mg) (1-(3-Cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid) |
28782-42-5 |
UN2811 |
| USP-1249905 |
Estazolam CIV (100 mg) |
29975-16-4 |
|
| 2933910000 |
|
|
|
| USP-1255850 |
Eszopiclone CIV (100 mg) |
138729-47-2 |
|
| 2933790002 |
|
|
|
| USP-1269083 |
Exemestane Related Compound C CIII (15 mg) (androsta-1,4-diene-3,17-dione) |
897-06-3 |
|
| 2937290000 |
|
|
|
| USP-1269902 |
Fentanyl CII (100 mg) |
437-38-7 |
UN2811 |
| USP-1269957 |
Fentanyl Related Compound E CII (10 mg) (N-Phenyl-1-(2-phenylethyl)-4-piperidinamine) |
21409-26-7 |
|
| 2933360000 |
|
|
|
| USP-1269979 |
Fentanyl Related Compound G CI (10 mg) (N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide) |
3258-84-2 |
UN2811 |
| USP-1270005 |
Fentanyl Citrate CII (100 mg) |
990-73-8 |
UN2811 |
| USP-1280009 |
Fluoxymesterone CIII (200 mg) |
76-43-7 |
|
| 2937290000 |
|
|
|
| USP-1285002 |
Flurazepam Hydrochloride CIV (200 mg) |
1172-18-5 |
|
| 2933910000 |
|
|
|
| USP-1314960 |
Hydrocodone CII (125 mg) |
125-29-1 |
|
| 2939110000 |
|
|
|
| USP-1315001 |
Hydrocodone Bitartrate CII (100 mg) |
34195-34-1 |
|
| 2939110000 |
|
|
|
| USP-1315012 |
Hydrocodone Related Compound A CII (70 mg) (4-hydroxy-3-methoxy-17-methylmorphinan-6-one) |
847-86-9 |
|
| 2939190000 |
|
|
|
| USP-1323000 |
Hydromorphone Hydrochloride CII (50 mg) |
71-68-1 |
UN2811 |
| USP-1323019 |
Hydromorphone N-Oxide Hydrochloride CII (15 mg) (4,5alpha-Epoxy-3-hydroxy-17-methylmorphinan-6-one N-oxide, hydrochloride) |
109648-80-8 (base) |
|
| 2939190000 |
|
|
|
| USP-1323021 |
Hydromorphone Related Compound A CII (10 mg) (7,8-didehydro-4,5alpha-epoxy-3-hydroxy-17-methylmorphinan-6-one perchlorate) |
91265-67-7 |
UN2811 |
| USP-1356009 |
Ketamine Hydrochloride CIII (250 mg) |
1867-66-9 |
|
| 2922390000 |
|
|
|
| USP-1357103 |
Lacosamide CV (250 mg) ((+)-(R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide) |
175481-36-4 |
UN2811 |
| USP-1364007 |
Levorphanol Tartrate CII (500 mg) |
67227-44-5 |
UN2811 |
| USP-1370305 |
Lorazepam CIV (200 mg) |
846-49-1 |
|
| 2933910000 |
|
|
|
| USP-1383001 |
Meperidine Hydrochloride CII (200 mg) |
50-13-5 |
UN2811 |
| USP-1386000 |
Mephobarbital CIV (250 mg) |
115-38-8 |
UN2811 |
| USP-1389008 |
Meprobamate CIV (200 mg) |
57-53-4 |
|
| 2924110000 |
|
|
|
| USP-1213318 |
Diosmin (300 mg) |
520-27-4 |
|
| 2932996560 |
|
|
|
| USP-1213329 |
Diosmin for System Suitability (15 mg) (a mixture of acetoisovanillone, hesperidin, isorhoifolin, diosmin, linarin and diosmetin) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1214004 |
Dioxybenzone (150 mg) |
131-53-3 |
|
| 2914500000 |
|
|
|
| USP-1217909 |
Diphenhydramine Citrate (200 mg) |
88637-37-0 |
|
| 2922190900 |
|
|
|
| USP-1218005 |
Diphenhydramine Hydrochloride (200 mg) |
147-24-0 |
|
| 2922190900 |
|
|
|
| USP-1218016 |
Diphenhydramine Related Compound A (25 mg) (2-(Diphenylmethoxy)-N-methylethanamine hydrochloride) |
53499-40-4 |
|
| 2922199695 |
|
|
|
| USP-1218027 |
Diphenhydramine Related Compound B (20 mg) (3-(benzhydryloxy)propane-1,2-diol) |
19574-66-4 |
|
| 2918992090 |
|
|
|
| USP-1218050 |
Diphenhydramine N-Oxide (25 mg) (2-(benzhydryloxy)-N,N-dimethylethan-1-amine oxide hydrochloride) |
13168-00-8 |
|
| 2922199695 |
|
|
|
| USP-1220357 |
Dipivefrin Related Compound E (25 mg) (4-[(Methylamino)acetyl]-1,2-phenylene dipivalate hydrochloride) |
N/A |
|
| 2922504500 |
|
|
|
| USP-1220506 |
Dipyridamole (200 mg) |
58-32-2 |
|
| 2933595960 |
|
|
|
| USP-1220517 |
Dipyridamole Related Compound A (25 mg) (2,2′-{[4,6,8-Tri(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol) |
16982-40-4 |
|
| 2933599550 |
|
|
|
| USP-1220528 |
Dipyridamole Related Compound B (25 mg) (2,2′,2”,2”’,2””,2””’-{[8-(Piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4,6-triyl]tris(azanetriyl)}hexaethanol) |
16908-47-7 |
|
| 2933599550 |
|
|
|
| USP-1220539 |
Dipyridamole Related Compound C (25 mg) (2,2′-{[6-chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol) |
54093-92-4 |
|
| 2933599550 |
|
|
|
| USP-1220540 |
Dipyridamole Related Compound D (25 mg) (2,2′-({6-[(2-Hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl}azanediyl)diethanol) |
1176886-12-6 |
|
| 2933599550 |
|
|
|
| USP-1220559 |
Dipyridamole Related Compound E (25 mg) (2,2′,2”,2”’-{[6,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4-diyl]bis(azanetriyl)}tetraethanol) |
N/A |
|
| 2933599550 |
|
|
|
| USP-1220561 |
Dipyridamole Related Compound F (25 mg) (2,2′,2”,2”’-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))tetraethanol) |
60286-30-8 |
|
| 2933599550 |
|
|
|
| USP-1221000 |
Disodium Guanylate (350 mg) |
5550/12/9 |
|
| 2934990005 |
|
|
|
| USP-1222400 |
Disodium 5′-Uridylate (500 mg) |
3387-36-8 |
|
| 2934990005 |
|
|
|
| USP-1222501 |
Disopyramide Phosphate (200 mg) |
22059-60-5 |
|
| 2933399095 |
|
|
|
| USP-1223005 |
2,4-Disulfamyl-5-Trifluoromethylaniline (50 mg) |
654-62-6 |
|
| 2935909550 |
|
|
|
| USP-1224008 |
Disulfiram (200 mg) |
97-77-8 |
UN3077 |
| USP-1224201 |
Divalproex Sodium (200 mg) |
76584-70-8 |
|
| 2915900000 |
|
|
|
| USP-1224507 |
Dobutamine Hydrochloride (400 mg) |
49745-95-1 |
|
| 2922299000 |
|
|
|
| USP-1224530 |
Dobutamine Related Compound C (50 mg) (N-(3,4-Dimethoxyphenethyl)-4-(4-methoxyphenyl)butan-2-amine hydrochloride) |
51062-14-7 |
|
| 2922299000 |
|
|
|
| USP-1224551 |
Docetaxel (200 mg) ((2R,3S)-N-Carboxy-3-phenylisoserine, N-tert-butyl ester, 13-ester with 5Beta,20-epoxy-1,2alpha,4,7Beta,10Beta,13alpha-hexahydroxytax-11-en-9-one 4-acetate 2-benzoate trihydrate) |
148408-66-6 |
|
| 2932996560 |
|
|
|
| USP-1224562 |
Docetaxel Identification (50 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1224573 |
Docetaxel System Suitability Mixture (15 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1224664 |
Docosyl Ferulate (50 mg) |
101927-24-6 |
|
| 2918992090 |
|
|
|
| USP-1224700 |
Docusate Calcium (500 mg) |
128-49-4 |
|
| 2917197055 |
|
|
|
| USP-1224802 |
Docusate Sodium (1 g) |
577-11-7 |
|
| 2917197055 |
|
|
|
| USP-1224824 |
Docusate Sodium Related Compound B (40 mg) (disodium mono (2-ethylhexyl) sulfosuccinate) |
N/A |
|
| 2917197055 |
|
|
|
| USP-1224904 |
Docusate Potassium (100 mg) |
7491-09-0 |
|
| 2917197055 |
|
|
|
| USP-1224937 |
Dofetilide (200 mg) |
115256-11-6 |
UN3077 |
| USP-1224948 |
Dofetilide Related Compound A (25 mg) (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide) |
176447-94-2 |
|
| 2935909550 |
|
|
|
| USP-1652500 |
Thalidomide (200 mg) |
50-35-1 |
UN2811 |
| USP-1652704 |
L-Theanine (200 mg) |
3081-61-6 |
|
| 2924190002 |
|
|
|
| USP-1653004 |
Theophylline (200 mg) |
58-55-9 |
UN2811 |
| USP-1653026 |
Theophylline Related Compound B (25 mg) (3-Methyl-1H-purine-2,6-dione) |
1076-22-8 |
|
| 2939590000 |
|
|
|
| USP-1653037 |
Theophylline Related Compound C (25 mg) (N-(6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide) |
7597-60-6 |
|
| 2933599550 |
|
|
|
| USP-1653048 |
Theophylline Related Compound D (30 mg) (N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide hydrochloride monohydrate) |
N/A |
|
| 2933290000 |
|
|
|
| USP-1653060 |
Theophylline Related Compound F (25 mg) (7-(2-Hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione) |
519-37-9 |
|
| 2939590000 |
|
|
|
| USP-1653117 |
Theophylline Melting Point Standard (2 x 500 mg) (Approximately 271 degrees) |
58-55-9 |
UN2811 |
| USP-1655000 |
Thiabendazole (100 mg) |
148-79-8 |
UN3077 |
| USP-1656002 |
Thiamine Hydrochloride (500 mg) (Vitamin B1 Hydrochloride) |
1967/3/8 |
|
| 2936220000 |
|
|
|
| USP-1659000 |
Thimerosal (500 mg) |
54-64-8 |
UN2025 |
| USP-1659001 |
Thimerosal Related Compound A (50 mg) (2,2′-Disulfanediyldibenzoic acid) |
119-80-2 |
|
| 2930902000 |
|
|
|
| USP-1660000 |
Thioguanine (200 mg) |
154-42-7 |
|
| 2933595960 |
|
|
|
| USP-1662504 |
Thioridazine (200 mg) |
50-52-2 |
|
| 2934302300 |
|
|
|
| USP-1663008 |
Thioridazine Hydrochloride (200 mg) |
130-61-0 |
|
| 2934302300 |
|
|
|
| USP-1663063 |
Thioridazine Related Compound F (20 mg) (2-(Methylthio)-10-[2-(piperidin-2-yl)ethyl]-10H-phenothiazine hydrochloride) |
13002-81-8 |
|
| 2934990005 |
|
|
|
| USP-1663700 |
Thiostrepton (200 mg) |
1393-48-2 |
|
| 2941906000 |
|
|
|
| USP-1664000 |
Thiotepa (100 mg) |
52-24-4 |
UN2811 |
| USP-1665003 |
Thiothixene (250 mg) |
3313-26-6 |
|
| 2935904000 |
|
|
|
| USP-1666006 |
(E)-Thiothixene (100 mg) |
3313-27-7 |
|
| 2935909550 |
|
|
|
| USP-1667100 |
Thonzonium Bromide (200 mg) |
553-08-2 |
|
| 2933599550 |
|
|
|
| USP-1667122 |
Tiagabine Isomer (25 mg) (1-(4,4-Bis(4-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic acid) |
109857-65-0 |
|
| 2934990005 |
|
|
|
| USP-1667133 |
Ticagrelor Related Compound B (25 mg) |
1788033-05-5 |
|
| 2933599550 |
|
|
|
| USP-1667144 |
Ticlopidine Hydrochloride (150 mg) |
53885-35-1 |
|
| 2934990005 |
|
|
|
| USP-1667155 |
Ticlopidine Related Compound A (20 mg) (4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine) |
68559-60-4 |
|
| 2934990005 |
|
|
|
| USP-1667166 |
Ticlopidine Related Compound B (20 mg) (5-(2-chlorobenzyl)-4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine) |
68559-55-7 |
|
| 2934990005 |
|
|
|
| USP-1667177 |
Ticagrelor (200 mg) |
274693-27-5 |
UN3077 |
| USP-1667188 |
Ticagrelor Related Compound A (25 mg) ((1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine (R)-mandelate) |
376608-71-8 |
UN2811 |
| USP-1667202 |
L-Threonine (200 mg) |
72-19-5 |
|
| 2922505000 |
|
|
|
| USP-1667213 |
Thymol (500 mg) |
89-83-8 |
UN3261 |
| USP-1667224 |
Tiagabine Related Compound A (15 mg) ((R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate, hydrochloride) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1667235 |
Racemic Tiagabine Hydrochloride Mixture (25 mg) ((S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid, hydrochloride) |
N/A |
|
| 2934990005 |
|
|
|
